MFS
XERS icon

Mirabella Financial Services’s Xeris Biopharma Holdings XERS Stock Holding History

Mirabella Financial Services’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,483
Closed -$130K – 1192
2026
Q1 		$130K Buy
+22,483
New +$149K 0.01% 843

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Mirabella Financial Services's XERS Position: Q2 2026 in Review

Mirabella Financial Services sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 22,483 shares — an estimated $130K sold.

Mirabella Financial Services first reported a position in XERS in Q1 2026 and held it in 1 quarter. The position peaked at $130K in Q1 2026. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Mirabella Financial Services reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 22,483 Xeris Biopharma Holdings shares in Q2 2026, an estimated $130K.
  • Mirabella Financial Services first reported a position in Xeris Biopharma Holdings in Q1 2026 and held it in 1 quarter.
  • Mirabella Financial Services's Xeris Biopharma Holdings position peaked at $130K in Q1 2026.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.